EMA is developing guidance for manufacturers planning changes to the existing COVID-19 vaccines to tackle the new virus variants. In order to consider options for additional testing and development of vaccines that are effective against new virus mutations, the Agency has requested all vaccine developers to investigate if their vaccine can offer protection against any […]
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]
European Medicines Agency (EMA)
Access to the official webpage and the social networks Role: EMA guarantees the scientific evaluation, supervision & safety monitoring of human & veterinary medicines in the EU. Executive Director: Emer Cooke Established in: 1995 Number of staff: 897 Location: Amsterdam (the Netherlands) Website: EMA The European Medicines Agency (EMA) protects and promotes human and animal health […]